@article{oai:nagasaki-u.repo.nii.ac.jp:00027390,
 author = {Shimizu, Yuji and Kawashiri, Shin-Ya and Nobusue, Kenichi and Nonaka, Fumiaki and Tamai, Mami and Honda, Yukiko and Yamanashi, Hirotomo and Nakamichi, Seiko and Kiyama, Masahiko and Hayashida, Naomi and Nagata, Yasuhiro and Maeda, Takahiro},
 issue = {1},
 journal = {Scientific Reports},
 month = {May},
 note = {Height loss starting in middle age is reportedly signifcantly associated with death due to cardiovascular disease. Impaired blood fow is the main pathology in cardiovascular disease. Hematopoietic stem cells such as CD34-positive cells play an important role in maintaining the microcirculation and preventing impaired blood fow by activating endothelial repair and angiogenesis. Therefore, circulating CD34-positive cell count could be associated with height loss. To clarify the association between circulating CD34-positive cell count and height loss, we conducted a follow-up study of 363 Japanese men aged 60–69 years over 2 years. Height loss was defned as being in the highest quartile of height decrease per year. Independent of known cardiovascular risk factors, circulating CD34-positive cell count was signifcantly inversely associated with height loss. The fully adjusted odds ratio (OR) and 95% confdence interval (CI) of height loss for circulating CD34-positive cell count (logarithmic values) was 0.49 (0.32, 0.74). This study suggests that a lower capacity to maintain the microcirculation due to a fewer CD34-positive cells might afect height loss., Scientific Reports, 12(1), art. no. 7175; 2022},
 title = {Association between circulating CD34‑positive cell count and height loss among older men},
 volume = {12},
 year = {2022}
}